Lord, Abbett & Co
CCRN icon

Lord, Abbett & Co’s Cross Country Healthcare CCRN Stock Holding History

Lord, Abbett & Co’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-330,266
Closed -$9.17M – 616
2021
Q4 		$9.17M Buy
+330,266
New +$8.01M 0.02% 504

Other funds holding CCRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Lord, Abbett & Co's CCRN Position: Q1 2022 in Review

Lord, Abbett & Co sold out of Cross Country Healthcare (CCRN) in Q1 2022, closing a stake of 330,266 shares — an estimated $9.17M sold.

Lord, Abbett & Co first reported a position in CCRN in Q4 2021 and held it in 1 quarter. The position peaked at $9.17M in Q4 2021. 195 funds tracked by Wall St. Rank hold CCRN as of Q1 2022.

  • Lord, Abbett & Co reported no remaining Cross Country Healthcare position as of Q1 2022 after selling out during the quarter.
  • Lord, Abbett & Co sold 330,266 Cross Country Healthcare shares in Q1 2022, an estimated $9.17M.
  • Lord, Abbett & Co first reported a position in Cross Country Healthcare in Q4 2021 and held it in 1 quarter.
  • Lord, Abbett & Co's Cross Country Healthcare position peaked at $9.17M in Q4 2021.
  • 195 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2022.

Based on Lord, Abbett & Co's 13F filing for Q1 2022, filed 13 May 2022.